Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Conduit reports strong premium growth, appoints permanent CEO

(Sharecast News) - Shares in Conduit surged on Wednesday after the company delivered a solid first-quarter update, approved a $50m share buyback and announced the appointment of founder and chairman Neil Eckert as its permanent chief executive. Conduit Holdings Limited, the parent company of Conduit Re, said that Eckert, who has been serving as interim boss since the retirement of Trevor Carvey in March, has been appointed as CEO with immediate effect.

Rebecca Shelley, a senior independent director who has now stepped into the non-executive chair role on an interim basis, said Eckert's "wealth of experience, strong leadership and intimate knowledge of the business and team make him the right leader to guide Conduit through its next phase of growth and maturity".

The appointment came as Conduit reported a 15% increase in gross written premiums in the first quarter to $410.2m, with growth registered across all three business segments of property, casualty and specialty.

Importantly for investors, the company said it has made no changes to its estimates for undiscounted ultimate net losses relating to the California wildfires, budgeting between $100m and $140m net of reinsurance and reinstatement premiums.

"Looking ahead, we continue to have confidence in our ability to deliver a target return on equity in the mid-teens across the insurance cycle," Eckert said.

"The board's decision to approve a share buyback programme further demonstrates its confidence in the value of Conduit's franchise and our commitment to deliver shareholder value."

Shares were up 8.3% at 377.5p by 0855 BST.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.